Biological Information

Background Information:

The receptor tyrosine kinase FLT-3 (fms-related tyrosine kinase 3, STK1) appears to play an important role in the development of hematopoietic stemcells, dendritic cells, B progenitor cells, and natural killer (NK) cells. On binding FLT3 ligand, the wild-type receptor dimerizes, activating its tyrosine kinase domain with resultant autophosphorylation. RAS-GAP, PLC-g, PI3-kinase, STAT5, and ERK1/2 are important signaling proteins linked to activation of FLT3. FLT3 is aberrantly expressed in the malignant cells in the majority of patients with acute myeloid leukemia (AML).

Family:

Kinase

Sub Family:

RTK

Class:

Protein Tyrosine

Protein Name:

FLT3

Uniprot Number:

P36888

Protein Aliases:

FL cytokine receptor|Fetal liver kinase-2|FLK-2|Fms-like tyrosine kinase 3|FLT-3|Stem cell tyrosine kinase 1|STK-1|CD antigen CD135

Gene Name:

FLT3

Gene ID:

2322

Gene Aliases:

STK1|FLK2|CD135

Accession Number:

NP_004110.2

Organism:

Human

Construct Details:

Wild Type; Partial Length (Start/Stop: H564/Y969); Mammalian Expression

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Testing Information

Test Sample Requirements:

50uL of a 1000X stock based on the top or final concentration being tested

Minimum Order Quantity:

24

Turnaround Time

Standard:

14 Business Days

Clinical Relevance

Adverse / Beneficial Action:

FLT3 inhibitors may lead to new approaches for the treatment of acute myeloid leukemia (AML) and other forms of cancer.

Additional Information

Brand:

LeadHunter

Testing Location:

USA - San Diego, CA